Pancreatic Cancer Research

ResearcherHelmholtz MunichNo recent work listed

Na Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-5511-4854; OpenAlex author ID A5026685270. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13550-021-00862-y↗
  2. Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-15-0165↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Axel Karl Walch · 2 shared papers, 2016–2021 · strength 0.17
  2. Jens Thomas Siveke · 2 shared papers, 2016–2021 · strength 0.17
  3. Iréne Esposito · 2 shared papers, 2016–2021 · strength 0.17
  4. Wilko Weichert · 1 shared paper, 2021 · strength 0.12
  5. Anna Melissa Schlitter · 1 shared paper, 2021 · strength 0.12
  6. Marija Trajkovic‐Arsic · 1 shared paper, 2021 · strength 0.12
  7. Michaela Aichler · 1 shared paper, 2016 · strength 0.05
  8. Barbara M. Grüner · 1 shared paper, 2016 · strength 0.05
  9. Alexander Herner · 1 shared paper, 2016 · strength 0.05
  10. Roland Michael Schmid · 1 shared paper, 2016 · strength 0.05
  11. Rickmer Braren · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.